Challenges and opportunities in current vaccine technology and administration: A comprehensive survey examining oral vaccine potential in the United States-Reference-Cited by-同舟云学术

Challenges and opportunities in current vaccine technology and administration: A comprehensive survey examining oral vaccine potential in the United States

Published:2022-09-09 Issue:6 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Rupassara S. Indu¹^ORCID,Kindt Jr John W.¹,Kazi Nazmul²^ORCID,Kahanda Indika²^ORCID

Affiliation:

1. Research Division, FruitVaccine, Inc., Champaign, IL, USA

2. School of Computing, University of North Florida, Jacksonville, FL, USA

Funder

NSF-SBIR

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2114422

Reference47 articles.

1. Centers for Disease Control and Prevention. Vaccine administration route and site. Atlanta (GA): Office of the Associate Director for Communication; 2021 [accessed 2022 Mar 1]. https://www.cdc.gov/vaccines/hcp/admin/administer-vaccines.html.

2. Centers for Disease Control and Prevention. Birth-18 years immunization schedule. Atlanta (GA): Office of the Associate Director for Communication; 2022 [accessed 2022 Mar 1]. https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html.

3. Centers for Disease Control and Prevention. Live intranasal influenza vaccine information statement. Atlanta (GA): Office of the Associate Director for Communication; 2021 [accessed 2022 Mar 1]. https://www.cdc.gov/vaccines/hcp/vis/vis-statements/flulive.html.

4. Centers for Disease Control and Prevention. Adenovirus vaccine information statement. Atlanta (GA): Office of the Associate Director for Communication; 2020 [accessed 2022 Mar 1]. https://www.cdc.gov/vaccines/hcp/vis/vis-statements/adenovirus.html.

5. Centers for Disease Control and Prevention. Cholera vaccine information statement. Atlanta (GA): Office of the Associate Director for Communication; 2019a [accessed 2022 Mar 1]. https://www.cdc.gov/vaccines/hcp/vis/vis-statements/cholera.html.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Supply Chain Logistics and Business Ecosystems Needed for the Development of Natural Vaccines with Novel, Safer, and Noninvasive Delivery Mechanisms;New Topics in Vaccine Development [Working Title];2023-12-23

2. Zero-Shot Information Extraction with Community-Fine-Tuned Large Language Models From Open-Ended Interview Transcripts;2023 International Conference on Machine Learning and Applications (ICMLA);2023-12-15

3. Perspective Chapter: Natural Adjuvants for Mucosal Vaccines—The Promise of Tomatine as an Inherent Adjuvant in Tomatoes;New Topics in Vaccine Development [Working Title];2023-11-14

4. Perspective Chapter: The Most Natural Possible Vaccine Administered in the Most Natural Possible Way - Noninvasive over Injectable Vaccine Delivery Routes;New Topics in Vaccine Development [Working Title];2023-11-14